Catalyst Pharmaceuticals Inc. (CPRX)

Catalyst Pharmaceuticals Inc. (CPRX $22.81)
- $22.81 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $477.73)
- $477.73 P/E (TTM): 61.34X Cap: $169.65B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $451.59)
- $451.59 P/E (TTM): 30.25X Cap: $114.71B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $208.34)
- $208.34 P/E (TTM): 93.12X Cap: $368.38B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $237.28)
- $237.28 P/E (TTM): 21.59X Cap: $571.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $918.05)
- $918.05 P/E (TTM): 40.54X Cap: $867.39B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $114.50)
- $114.50 P/E (TTM): 15.92X Cap: $283.08B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $163.78)
- $163.78 P/E (TTM): 20.63X Cap: $7.90B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $577.12)
- $577.12 P/E (TTM): 44.88X Cap: $45.89B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $63.65)
- $63.65 P/E (TTM): 25.74X Cap: $7.51B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $92.24)
- $92.24 P/E (TTM): 14.7X Cap: $18.35B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $22.81)
- $22.81 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.66)
- $28.66 P/E (TTM): 380.0X Cap: $245.38B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

AbbVie Inc. (ABBV $208.34)
- $208.34 P/E (TTM): 93.12X Cap: $368.38B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $918.05)
- $918.05 P/E (TTM): 40.54X Cap: $867.39B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $17.28)
- $17.28 P/E (TTM): 18.49X Cap: $436M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $63.65)
- $63.65 P/E (TTM): 25.74X Cap: $7.51B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $14.73)
- $14.73 Cap: $996M
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $22.81)
- $22.81 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Catalyst Pharmaceuticals Inc. (CPRX $22.81)
- $22.81 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX
Elevance Health Inc. (ELV $294.95)
- $294.95 P/E (TTM): 11.78X Cap: $65.09B
- View ELV Profile
- View Questions on ELV

Q: What's your opinion about these two stocks? Buy/Hold/Sell? Timeframe: 3-5 years. Risk tolerance: moderate.

Read Answer Asked by Paul on September 12, 2025